Antiatherogenic and Cardioprotective Effects of a Xanthine Derivative KMUP-1 in ApoE Knockout Mice

Erna Sulistyowati1, Shang-En Huang2, Chih-Chieh Hsu2

  • 1Department of Medicine, Faculty of Medicine, Universitas Islam Malang, Malang, East Java, Indonesia.

PubMed

Insights

The xanthine derivative KMUP-1 effectively combats atherosclerosis and cardiac remodeling in ApoE knockout mice by reducing inflammation and promoting autophagy, suggesting its therapeutic potential for cardiovascular diseases.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Molecular Biology

Background:

  • Atherosclerosis and cardiac remodeling are key drivers of cardiovascular disease.
  • Understanding disease progression mechanisms is crucial for effective management.
  • Xanthine derivatives are being explored for therapeutic potential.

Purpose of the Study:

  • To investigate the effects of KMUP-1 on atherosclerosis and cardiac remodeling.
  • To elucidate the underlying mechanisms of KMUP-1's action.
  • To evaluate KMUP-1 as a potential therapeutic agent for cardiovascular diseases.

Main Methods:

  • Atherosclerosis and cardiac damage induced in ApoE knockout mice using a high-fat diet.
  • Co- and posttreatment with KMUP-1 evaluated.
  • Biochemical assays (ELISA), histological staining (Oil Red O, H&E), echocardiography, immunofluorescence, and Western blotting used.

Main Results:

  • KMUP-1 significantly reduced body weight gain, aortic plaque area, and vascular thickness.
  • Reduced serum levels of inflammatory cytokines (IL-1β, TNF-α, IL-6, MCP-1).
  • Attenuated cardiac hypertrophy, restored cardiac function, improved lipid profiles, and modulated apoptosis/autophagy markers (Bax, Bcl-2, ATG7, LC3-II).

Conclusions:

  • KMUP-1 treatment, both concurrently and subsequently, mitigates atherosclerosis and cardiac remodeling in a mouse model.
  • KMUP-1 stimulates autophagy while reducing inflammation and apoptosis.
  • KMUP-1 demonstrates significant potential as a therapeutic agent for cardiovascular diseases.